abstract |
A method of treating GSI-responsive T cell leukemia that does not respond to a Notch1-specific antagonist. Methods of treating cancer, particularly leukemia, generally using Notch1 and Notch3 antagonists, alone or in combination, and compositions and methods for the treatment and diagnosis of Notch-related cancer. [Selection figure] None |